157 related articles for article (PubMed ID: 34944522)
21. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
Wu D; Hu S; Hou Y; He Y; Liu S
BMC Cancer; 2020 Mar; 20(1):199. PubMed ID: 32164602
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion.
Li Y; Chen X; Lu H
Oncol Res; 2016 Oct; 24(6):511-519. PubMed ID: 28281971
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the isoforms of type IIb sodium-dependent phosphate cotransporter (Slc34a2) in yellow catfish, Pelteobagrus fulvidraco, and their vitamin D
Chen P; Huang Y; Bayir A; Wang C
Fish Physiol Biochem; 2017 Feb; 43(1):229-244. PubMed ID: 27620186
[TBL] [Abstract][Full Text] [Related]
24. SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3β-mediated activation of Wnt/β-catenin signaling.
Chen J; Wang P; Cai R; Peng H; Zhang C; Zhang M
FEBS Open Bio; 2019 Mar; 9(3):527-537. PubMed ID: 30868061
[TBL] [Abstract][Full Text] [Related]
25. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
Yin BW; Kiyamova R; Chua R; Caballero OL; Gout I; Gryshkova V; Bhaskaran N; Souchelnytskyi S; Hellman U; Filonenko V; Jungbluth AA; Odunsi K; Lloyd KO; Old LJ; Ritter G
Cancer Immun; 2008 Feb; 8():3. PubMed ID: 18251464
[TBL] [Abstract][Full Text] [Related]
27. A frame-shift mutation in the SLC34A2 gene in three patients with pulmonary alveolar microlithiasis in an inbred family.
Dogan OT; Ozsahin SL; Gul E; Arslan S; Koksal B; Berk S; Ozdemir O; Akkurt I
Intern Med; 2010; 49(1):45-9. PubMed ID: 20046000
[TBL] [Abstract][Full Text] [Related]
28. 3D culture system containing gellan gum restores oncogene dependence in ROS1 rearrangements non-small cell lung cancer.
Gong B; Oh-Hara T; Fujita N; Katayama R
Biochem Biophys Res Commun; 2018 Jun; 501(2):527-533. PubMed ID: 29738763
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.
Huqun ; Izumi S; Miyazawa H; Ishii K; Uchiyama B; Ishida T; Tanaka S; Tazawa R; Fukuyama S; Tanaka T; Nagai Y; Yokote A; Takahashi H; Fukushima T; Kobayashi K; Chiba H; Nagata M; Sakamoto S; Nakata K; Takebayashi Y; Shimizu Y; Kaneko K; Shimizu M; Kanazawa M; Abe S; Inoue Y; Takenoshita S; Yoshimura K; Kudo K; Tachibana T; Nukiwa T; Hagiwara K
Am J Respir Crit Care Med; 2007 Feb; 175(3):263-8. PubMed ID: 17095743
[TBL] [Abstract][Full Text] [Related]
30. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
31. Eight novel variants in the
Jönsson ÅLM; Bendstrup E; Mogensen S; Kopras EJ; McCormack FX; Campo I; Mariani F; Escribano-Montaner A; Holm AM; Martinez-Colls MDM; Pintos-Morell G; Taillé C; Crestani B; Hilberg O; Hvarregaard Christensen J; Simonsen U
Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31831582
[TBL] [Abstract][Full Text] [Related]
32. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.
Levan K; Mehryar M; Mateoiu C; Albertsson P; Bäck T; Sundfeldt K
BMC Cancer; 2017 May; 17(1):303. PubMed ID: 28464843
[TBL] [Abstract][Full Text] [Related]
34. Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer.
Nurgalieva AK; Popov VE; Skripova VS; Bulatova LF; Savenkova DV; Vlasenkova RA; Safina SZ; Shakirova EZ; Filonenko VV; Bogdanov MV; Kiyamova RG
Biochem Biophys Rep; 2021 Dec; 28():101104. PubMed ID: 34504954
[TBL] [Abstract][Full Text] [Related]
35. SLC34A2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer.
Yang Y; Wu J; Yu X; Wu Q; Cao H; Dai X; Chen H
Pathol Res Pract; 2022 Jan; 229():153706. PubMed ID: 34929599
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis.
Zhao Y; Zhu Z; Shi S; Wang J; Li N
Biomed Pharmacother; 2019 Dec; 120():109457. PubMed ID: 31585300
[TBL] [Abstract][Full Text] [Related]
37. Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian Cancers.
Lin K; Rubinfeld B; Zhang C; Firestein R; Harstad E; Roth L; Tsai SP; Schutten M; Xu K; Hristopoulos M; Polakis P
Clin Cancer Res; 2015 Nov; 21(22):5139-50. PubMed ID: 26156394
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of the intestinal phosphate transporter SLC34A2 by the protein kinase mTOR.
Shojaiefard M; Lang F
Biochem Biophys Res Commun; 2006 Jul; 345(4):1611-4. PubMed ID: 16730658
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic gene changes determine the successful establishment of stable renal cancer cell lines from tumor tissue.
Feng H; Zhang Y; Liu K; Zhu Y; Yang Z; Zhang X; Liu Y
Int J Cancer; 2017 Jun; 140(11):2526-2534. PubMed ID: 28256713
[TBL] [Abstract][Full Text] [Related]
40. SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis.
Jönsson ÅL; Hilberg O; Bendstrup EM; Mogensen S; Simonsen U
Am J Respir Crit Care Med; 2012 Feb; 185(4):464. PubMed ID: 22336687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
